The relationship between internalizing symptoms and psychotic-like experiences was similar for probable depression (OR, 1.08; 95% CI, 1.03-1.14; P =.003) and anxiety disorder (OR, 1.11; 95% CI, 1.05-1.17; P <.001).
According to the researchers, other published data suggest that visual deprivation causes increases in NMDAR-dependent cortical excitability.
Greater severity of depressive symptoms was significantly associated with increased severity of positive (P =.002) and negative (P =.003) schizophrenia symptoms.
A tenfold increase in the prevalence of schizophrenia in patients with HS underscores the importance of screening for severe mental illness, as comorbid psychiatric disorders may affect treatment outcomes.
A Finnish study published in BMJ found key differences in the conceptions of psychiatric diseases among the general public, physicians, nurses, and legislators.
Although prior research suggests that heritability accounts for 66% to 85% of schizophrenia risk, additional risk factors include stress and the “nature of caregiving,” or the home environment and caregiver conduct.
Previously, young adults were not covered by their parents’ private insurance plans once they were no longer full-time students, leaving a substantial number of young adults experiencing early-onset psychosis without healthcare coverage.
Response to treatment for negative symptoms was greater in patients in the tDCS arm compared with patients in the sham arm at weeks 6 and 12 (both P <.001).
Researchers evaluated a smartphone intervention designed to manage lingering symptoms in schizophrenia spectrum disorders.
The FDA has approved Secuado (asenapine; Noven) transdermal system for the treatment of adults with schizophrenia.
